March 24, 2009 - Efficacy and safety study results for Corthera's investigational drug relaxin for the treatment of acute heart failure (AHF) will be presented Sunday, March 29, during the American College of Cardiology's (ACC) 58th Annual Scientific Session in Orlando, FL.
March 24, 2009 - Frost & Sullivan has awarded Philips Healthcare with the 2009 North American Frost & Sullivan Product Innovation of the Year Award for its Brilliance iCT 256 slice and iCT SP 128 slice computed tomography (CT) systems.
March 24, 2009 - The Society of Chest Pain Centers’ new Acute Heart Failure Center Accreditation program is aimed at helping healthcare facilities improve patient outcomes and reduce costs through the use of process improvement methods to optimize best practices.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
With the uncertain economic environment, many organizations are challenged by having to align shrinking budgets with their training and development needs. While professional development remains an essential part of organizational health, it can be costly, too.
March 23, 2009 – The FDA has cleared the Nellcor OxiMax N-600x pulse oximeter with OxiMax SPD alert for adults, which enables the pulse oximeter to detect and alert clinicians of oxygen desaturation patterns, allowing them to make timely and more informed decisions about patient care.
March 23, 2009 - CircuLite Inc.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 23, 2009 - Pathway Medical Technologies Inc. today said the FDA granted the company 510(k) clearance to market the Jetstream G2 specifically for use in breaking apart and removing thrombus (or blood clots) from the upper and lower extremity peripheral arteries.
March 23, 2009 - FiatLux Imaging and Panasonic Computer Solutions Co. will demonstrate at HIMSS 2009 the advanced visualization capabilities of FiatLux Visualize optimized for the next generation of tablet computers for the healthcare industry including the new the Panasonic Toughbook H1 Mobile Clinical Assistant (MCA).
During TCT 2009 this past fall in Washington D.C. I had the chance to listen to Shigeru Saito, M.D., FACC, ShonanKamakura General Hospital, Sapporo, Japan, explain reasons why he feels transradial artery access for interventional procedures is better than the U.S. standard of femoral access. Dr.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 20, 2009 - Stanford University School of Medicine researchers have pooled three years of individual patient data to compare the effectiveness of coronary artery bypass surgery versus angioplasty on specific groups of patients.
March 20, 2009 - Stanford University School of Medicine researchers have pooled three years of individual patient data to compare the effectiveness of coronary artery bypass surgery versus angioplasty on specific groups of patients.
March 20, 2009 - Endologix Inc. yesterday announced the first presentation of initial outcomes with up to two-year patient follow-up from its Powerlink Suprarenal Proximal Extension trial; the Powerlink System is for the minimally invasive treatment of abdominal aortic aneurysms (AAA).
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
March 19, 2009 – The enrollment phase of the RAFT clinical trial (Resynchronization/Defibrillation for Ambulatory Heart Failure Trial) is complete, announced Medtronic Inc.
March 20, 2009 – MEDRAD Inc. Multi Vendor Service has launched TotalRepair, reportedly the first and only guaranteed repair solution on select ultrasound probes. Enabled by 100 percent repair capabilities, TotalRepair aims to allow healthcare facilities to spend less on costly exchanges and replacements by maximizing the use of probe repair.
March 20, 2009 - ARCA biopharma Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, said today two Gencaro (bucindolol hydrochloride) abstracts will be presented as poster sessions at the American College of Cardiology 58th Annual Scientific Session March 29-31, 2009 in Orlando, FL.